Care beyond microbiological cure: A case control study comparing quality of life between MDRTB and drug-sensitive TB patients

超越微生物治愈的关怀:一项比较耐多药结核病患者和药物敏感性结核病患者生活质量的病例对照研究

阅读:1

Abstract

BACKGROUND: The emergence of drug-resistant tuberculosis has become a significant public health problem and an obstacle to end tuberculosis. Despite the considerable attention given to traditional microbiological and clinical indicators in National TB programs, the effect of tuberculosis on the quality of life of patients has largely been neglected. This study was planned to compare the quality of life of MDR pulmonary tuberculosis with the drug-sensitive pulmonary tuberculosis and to find the association of different domains of quality of life with selected socio-demographic variables. METHODS: This is a facility-based observational analytical study done at a District Tuberculosis Centre, Kolkata, with MDR adult pulmonary tuberculosis patients as cases and drug-sensitive adult pulmonary tuberculosis patients as controls selected in a 1:2 ratio (114 cases and 228 controls). WHOQOL BREF was used to estimate quality of life. RESULTS: Wilcoxon signed rank test revealed a significant statistical difference in the mean value of quality-of-life transformed scores across each domain of WHO QOL BREF between cases and the control group (P < 0.001). QOL scores were compared by domains according to selected socio-demographic parameters, where sex, age, marital status, and educational status showed a significant statistical difference. Presence of comorbidity, being underweight, and history of tuberculosis have statistically significantly lower transformed score (P < 0.001) across all domains. CONCLUSION: The score of the MDR TB group was found to be lower than that of drug-sensitive TB group. A special package including the appointment of a counsellor at the point of treatment may be beneficial.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。